Evidence map›Paper›PMID 40855190›Full record

ArticleNature medicine2025

Pig-to-human lung xenotransplantation into a brain-dead recipient.

Jianxing He, Jiang Shi, Chao Yang, Guilin Peng, Chunrong Ju, Yi Zhao, Hui Liu, Ping He, Xiaoqing Liu, Zuopeng Zhang and 17 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Nature medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Transgenic expression of human CD47 on pig cells provides only partial protection against human macrophage-mediated destruction in human immune system mice.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. The Top 12 Most Impactful Papers in Clinical Transplantation in 2025: TI Editors' Choice.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Article
  16. Review
  17. Regulatory approach to manipulated organs in Europe: preserving human organs as non-commercial goods.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Jianxing He *Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Centre for Respiratory Disease, Guangzhou, China. drjianxing.he@gmail.com.ORCID http://orcid.org/0000-0003-1737-8192
Jiang Shi *Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Centre for Respiratory Disease, Guangzhou, China.
Chao Yang *Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Centre for Respiratory Disease, Guangzhou, China.
Guilin Peng *Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Centre for Respiratory Disease, Guangzhou, China.
Chunrong Ju *Department of Organ Transplantation, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Centre for Respiratory Disease, Guangzhou, China.
Yi ZhaoDepartment of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Centre for Respiratory Disease, Guangzhou, China.
Hui LiuDepartment of Anesthesiology, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Centre for Respiratory Disease, Guangzhou, China.
Ping HeDepartment of Pathology, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Centre for Respiratory Disease, Guangzhou, China.
Xiaoqing LiuDepartment of Critical Care Medicine, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Centre for Respiratory Disease, Guangzhou, China.
Zuopeng ZhangDepartment of Emergency Medicine, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Centre for Respiratory Disease, Guangzhou, China.
Chuanbao ChenDepartment of Organ Transplantation, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Centre for Respiratory Disease, Guangzhou, China.
Dengke PanChengdu Clonorgan Biotechnology Co. Ltd, Chengdu, China.ORCID http://orcid.org/0000-0002-7994-1465
Zifeng YangState Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Centre for Respiratory Disease, Guangzhou, China.ORCID http://orcid.org/0000-0002-2681-4171
Wenda GuangState Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Centre for Respiratory Disease, Guangzhou, China.
Hongtao LiAnimal Experiment Center, State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Centre for Respiratory Disease, Guangzhou, China.
Zhonghua ChenInstitute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Menyang LiuDepartment of Organ Transplantation, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Centre for Respiratory Disease, Guangzhou, China.
Hengrui LiangDepartment of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Centre for Respiratory Disease, Guangzhou, China.ORCID http://orcid.org/0000-0002-1155-5963
Weiqing HuangDepartment of Emergency Medicine, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Centre for Respiratory Disease, Guangzhou, China.
Kyeongman JeonDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0002-4822-1772
Toyofumi F Chen-YoshikawaDepartment of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
A Justin RuckerDivision of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, NC, USA.
Amos LalDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Nanshan ZhongDepartment of Allergy and Clinical Immunology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Disease, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou, China.ORCID http://orcid.org/0000-0003-2515-5589
Kang ZhangNational Clinical Eye Research Center of Eye Hospital and Institute for Clinical Data Science, Wenzhou Medical University, Wenzhou, China.ORCID http://orcid.org/0000-0002-4549-1697
Xiaoyou LiuDepartment of Organ Transplantation, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Centre for Respiratory Disease, Guangzhou, China. 9054400@qq.com.ORCID http://orcid.org/0009-0001-3446-8512
Xin XuDepartment of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, National Clinical Research Centre for Respiratory Disease, Guangzhou, China. yichunrenjia@126.com.ORCID http://orcid.org/0000-0001-8184-8326

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetically engineered pig lungs have not previously been transplanted into humans, leaving key questions unanswered regarding the human immune response in the context of a xenotransplanted lung and the possibility of hyperacute rejection. Here, we report a case of pig-to-human lung xenotransplantation, in which a lung from a six-gene-edited pig was transplanted into a 39-year-old brain-dead male human recipient following a brain hemorrhage. The lung xenograft maintained viability and functionality over the course of the 216 hours of the monitoring period, without signs of hyperacute rejection or infection. Severe edema resembling primary graft dysfunction was observed at 24 hours after transplantation, potentially due to ischemia-reperfusion injury. Antibody-mediated rejection appeared to contribute to xenograft damage on postoperative days 3 and 6, with partial recovery by day 9. Immunosuppression included rabbit anti-thymocyte globulin, basiliximab, rituximab, eculizumab, tofacitinib, tacrolimus, mycophenolate mofetil and tapering steroids, with adjustments made during the postoperative period based on assessments of immune status. Although this study demonstrates the feasibility of pig-to-human lung xenotransplantation, substantial challenges relating to organ rejection and infection remain, and further preclinical studies are necessary before clinical translation of this procedure.

Indexed as

Brain DeathLungLung TransplantationTransplantation, HeterologousAdultAnimalsAnimals, Genetically ModifiedGraft RejectionHeterograftsHumansMaleSwine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.